Welcome to CDC stacks | Supplementary figure 1. Characteristics of persons receiving naloxone through prescriptions dispensed at retail pharmacies — United States, 2018 - 79933 | Morbidity and Mortality Weekly Report (MMWR)
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Supplementary figure 1. Characteristics of persons receiving naloxone through prescriptions dispensed at retail pharmacies — United States, 2018
Filetype[PDF-407.87 KB]


Details:
  • Supporting Files:
    No Additional Files
You May Also Like:
  1. Vital Signs: Pharmacy-Based Naloxone Dispensing — United States, 2012–2018
    Personal Author:
    Guy, Gery P.; Haegerich, Tamara M.; Evans, Mary E.; Losby, Jan L.; Young, Randall; Jones, Christopher M.;
    Published:
    August 09 2019
    Source:
    MMWR Morb Mortal Wkly Rep. 68(31):679-686
    Series:
    CDC Vital signs ; Aug. 2019
    Description:
    Background : The CDC Guideline for Prescribing Opioids for Chronic Pain recommends considering prescribing naloxone when factors that increase risk for overdose are present (e.g., history of overdose or substance use disorder, opioid dosages ≥50 mo...
    File Type:
    Filetype[PDF - 2.51 MB]
  2. Vital Signs : Pharmacy-based Naloxone dispensing — United States, 2012–2018
    Personal Author:
    Gery P. Guy Jr.,; Tamara M. Haegerich,; Mary E. Evans,; Jan L. Losby,; Randall Young,; Christopher M. Jones, P;
    Corporate Author:
    National Center for Injury Prevention and Control (U.S.). Division of Unintentional Injury Prevention.. United States. Agency for Toxic Substances and Disease Registry. Division of Toxicology and Human Health Sciences..
    Published:
    August 6, 2019
    Series:
    MMWR. Morbidity and mortality weekly report ; v. 68, early release, August 6, 2019
    CDC Vital signs ; Aug. 2019
    Description:
    Background: The CDC Guideline for Prescribing Opioids for Chronic Pain recommends considering prescribing naloxone when factors that increase risk for overdose are present (e.g., history of overdose or substance use disorder, opioid dosages ≥50 mor...
    File Type:
    Filetype[PDF - 2.86 MB]
  3. MMWR. Morbidity and Mortality Weekly Report, Vol. 68, no. 31, August 9, 2019
    Corporate Author:
    Centers for Disease Control and Prevention (U.S.)
    Published:
    August 9, 2019
    Series:
    MMWR. Morbidity and mortality weekly report ; v. 68, no. 31
    Description:
    West Nile Virus and Other Domestic Nationally Notifiable Arboviral Diseases — United States, 2018 / Emily McDonald, MD; Stacey W. Martin, MSc; Kimberly Landry, MPH; et al. — Vital Signs: Pharmacy-Based Naloxone Dispensing — United States, 2012â...
    File Type:
    Filetype[PDF - 2.78 MB]
  4. Supplementary figure 2. Naloxone prescriptions dispensed by retail pharmacies by method of payment and out-of-pocket costs — United States, 2018
    Published:
    08/09/2019
    Source:
    MMWR Morb Mortal Wkly Rep. 2019; 68 (31):679-686.
    Series:
    MMWR. Morbidity and mortality weekly report ; v. 68, early release, August 6, 2019
    Description:
    Vital Signs - Naloxone Dispensing SUPPLEMENTARY FIGURE 2
    File Type:
    Filetype[PDF - 411.39 KB]
  5. Emergency Hospitalizations for Unsupervised Prescription Medication Ingestions by Young Children
    Personal Author:
    Lovegrove, Maribeth C.; Mathew, Justin; Hampp, Christian; Governale, Laura; Wysowski, Diane K.; Budnitz, Daniel S.;
    Published:
    September 15 2014
    Source:
    Pediatrics. 134(4):e1009-e1016
    Description:
    Background : Emergency department visits and subsequent hospitalizations of young children following unsupervised ingestions of prescription medications are increasing despite widespread use of child-resistant packaging and caregiver education effort...
    File Type:
    Filetype[PDF - 422.00 KB]